Mobile Apps for DNA Sequencing: Global Markets
The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.
- An in-depth analysis of the mobile applications of DNA sequencing, which is a developing personalized healthcare technique with enormous market potential.
- Analyses of market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- A look at the current and future expectations regarding the cost of individual DNA mapping procedures
- Quantification of the DNA sequencing markets by product type, indication, and geography
- Insight into developers of apps, and how DNA mapping and apps combine to produce modern ways of recording information
- Comprehensive discussion covering DNA sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
- Patent analysis
- Company profiles of major players in the DNA sequencing sector, including 23andMe, Helix, Illumina, Thermo Fisher Scientific, and Roche
This report is a comprehensive business tool, designed to provide an in-depth look at mobile applications of DNA sequencing. The geographical scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare sector and its participants and trends for the future.
Areas discussed include current funding being provided by the National Institutes of Health (NIH) in the U.S. and the National Health Service (NHS) in the U.K., which are at the forefront of this developing market. Funding worldwide is discussed in this report, together with the thought processes behind applying precision medicine to healthcare services.
Clinical trials are discussed in the report, together with developing technologies, software and cloud data storage, which are driving the translational science market for future precision medicine healthcare.
Categories discussed in the report include applications of:
- DNA sequencing/mapping.
- Genome sequencing/mapping.
- Gene sequencing/mapping.
- Exome sequencing.
- Targeted sequencing.
Devices for individual use, which in the main use Android or iOS operating systems, are discussed briefly. While the device market is not specifically part of this report, the developing technology will be used for the future of this market, including:
The end-use segments discussed in the report are:
- Computational biology/rare diseases.
Categories, platform segments and regions are discussed in detail, including describing and identifying current products on the market, measuring the market size, and market drivers with a forecast to 2022. Competitors are assessed, together with their respective market shares. For the country-level breakdown of segments, only the base year 2017 and projections to 2022 are indicated in the data in the tables. Year-to-year differences are considered as statistically insignificant.
The market evaluation in the study pertains to existing processes and/or devices used in the mobile application of DNA sequencing, and which have been developed and approved for human clinical use. The market size takes this into account. Options/upgrades or refurbished/remarketed equipment has not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services also related to the application of DNA sequencing conditions are discussed. Metrics countrywide, using information at the country level to look at the dynamics and their impact on reviews and growth, are used. Interviews were used to confirm and/or adjust the U.S. market size and market share estimates, as well as formulating market projections.
This report concentrates on the processes behind DNA sequencing techniques and discusses the developers of DNA sequencing and mobile applications of DNA sequencing and the history, processes and future developments being used to create and develop mobile applications.
Included in the report is a general overview of the genetic processes and terms used in the main areas of genomic studies and preparations. The report provides an outline only of the main areas involved with DNA sequencing.
This is a new market moving forward into revolutionary global healthcare through precision medicine. This report therefore reflects the new apps that have just become available in the market, together with developing technology. Clinical trials pertaining to moving toward the new global healthcare of precision medicine is studied in this report.
Included in the report is the developing market in the bioinformatics field of genetics and translational medicine from current standard medical practices to medical practices involving computational biology. Some devices studied in the report touch on the current and future market. The devices forecasted in the report are those that pertain to the current developing mobile apps market.
Specifically excluded from the study, as it is considered beyond the scope of the report, is an in-depth study of individuals who have had their DNA sequenced or mapped. Also excluded from the report is a detailed, in-depth study of the types of technology and methodology and terminology used, although this is outlined in general. Also excluded from the report is a detailed study of all the processes involved in genetics/genomes/sequencing as this topic is too vast in itself to explore in this report.
Also excluded from the report is a detailed description of all types of DNA sequencing, although the main areas in this topic are discussed, a further detailed in-depth examination of DNA sequencing is not deemed to be necessary for market values.
Considered outside the scope of this report is a detailed study of current mobile device technology, such as Android phones, PCs or tablets, as this report does not concentrate on this side of technological developments.
The analyst of this report, Smruti Munshi, has specialized in the medical technologies space for more than five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking, and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets, ranging from market insights, industry overviews to comprehensive marketing and technology-oriented custom consulting. Ms. Munshi has an MS in Biomedical Engineering and a BS in Instrumentation and Control Engineering. She has authored several reports for BCC Research in the medical field.